Literature DB >> 11083065

Ouabain, a new steroid hormone of adrenal gland and hypothalamus.

W Schoner1.   

Abstract

Ouabain has been isolated and identified as a constituent of human blood, bovine adrenal glands and hypothalamus. This water soluble inhibitor of the sodium pump (Na+/K+-ATPase) circulates in elevated concentrations in blood plasma of 50% of Caucasians with elevated blood pressure. It is released from adrenal cortical cells in tissue culture by angiotensin II. A ouabain antagonist, PST2238, lowers blood pressure in hypertensive rats. Hence, ouabain is most probably a new steroid hormone formed in adrenal glands and hypothalamus. Consistent therewith is the demonstration of a specific binding globulin for cardiac glycosides in blood plasma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083065     DOI: 10.1055/s-2000-8140

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  18 in total

Review 1.  Regulation of sodium/potassium ATPase activity: impact on salt balance and vascular contractility.

Authors:  A Aperia
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

2.  Na+, K+ ATPase activity is reduced in amygdala of rats with chronic stress-induced anxiety-like behavior.

Authors:  Leonardo Crema; Michele Schlabitz; Bárbara Tagliari; Aline Cunha; Fabrício Simão; Rachel Krolow; Letícia Pettenuzzo; Christianne Salbego; Deusa Vendite; Angela T S Wyse; Carla Dalmaz
Journal:  Neurochem Res       Date:  2010-08-18       Impact factor: 3.996

3.  Immunomodulatory activity of ouabain in Leishmania leishmania amazonensis-infected Swiss mice.

Authors:  P L Jacob; J A Leite; A K A Alves; Y K S Rodrigues; F M Amorim; P L N Néris; M R Oliveira; S Rodrigues-Mascarenhas
Journal:  Parasitol Res       Date:  2012-10-04       Impact factor: 2.289

4.  Ouabain, a steroid hormone that signals with slow calcium oscillations.

Authors:  O Aizman; P Uhlén; M Lal; H Brismar; A Aperia
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

5.  Targeted mutations in the Na,K-ATPase α 2 isoform confer ouabain resistance and result in abnormal behavior in mice.

Authors:  Tori L Schaefer; Jerry B Lingrel; Amy E Moseley; Charles V Vorhees; Michael T Williams
Journal:  Synapse       Date:  2010-11-17       Impact factor: 2.562

6.  Ouabain promotes partial epithelial to mesenchymal transition (EMT) changes in human autosomal dominant polycystic kidney disease (ADPKD) cells.

Authors:  Jessica Venugopal; Jeffrey McDermott; Gladis Sanchez; Madhulika Sharma; Leandro Barbosa; Gail A Reif; Darren P Wallace; Gustavo Blanco
Journal:  Exp Cell Res       Date:  2017-04-03       Impact factor: 3.905

7.  Ouabain attenuates ovalbumin-induced airway inflammation.

Authors:  José Guilherme F M Galvão; Luiz Henrique Agra Cavalcante-Silva; Deyse Cristina M Carvalho; Laércia Karla D P Ferreira; Talissa Mozzini Monteiro; Adriano Francisco Alves; Larissa Adilis M P Ferreira; Francisco Allysson A F Gadelha; Marcia Regina Piuvezam; Sandra Rodrigues-Mascarenhas
Journal:  Inflamm Res       Date:  2017-09-13       Impact factor: 4.575

8.  Na,K-ATPase activity regulates AMPA receptor turnover through proteasome-mediated proteolysis.

Authors:  Dawei Zhang; Qingming Hou; Min Wang; Amy Lin; Larissa Jarzylo; Allison Navis; Aram Raissi; Fang Liu; Heng-Ye Man
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

9.  Exocytotic release of [3H]-acetylcholine by ouabain involves intracellular Ca2+ stores in rat brain cortical slices.

Authors:  Rosangela S Lomeo; Renato S Gomez; Marco Antonio M Prado; Marco Aurélio Romano-Silva; André R Massensini; Marcus V Gomez
Journal:  Cell Mol Neurobiol       Date:  2003-12       Impact factor: 5.046

10.  Anti-inflammatory and antinociceptive activity of ouabain in mice.

Authors:  Danielle Ingrid Bezerra de Vasconcelos; Jacqueline Alves Leite; Luciana Teles Carneiro; Márcia Regina Piuvezam; Maria Raquel Vitorino de Lima; Liana Clébia Lima de Morais; Vivian Mary Rumjanek; Sandra Rodrigues-Mascarenhas
Journal:  Mediators Inflamm       Date:  2011-05-26       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.